SOFIA LUNA: Open Payments
NPI 1518177138 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 89 payments from 20 companies in 2025. Trend: 2023 $1,593 · 2024 $2,356 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $415 |
| PFIZER INC. | 19 | $142 |
| Sumitomo Pharma America, Inc. | 4 | $75 |
| SANOFI-AVENTIS U.S. LLC | 3 | $54 |
| Corcept Therapeutics | 3 | $50 |
| Amgen Inc. | 3 | $44 |
| Dexcom, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: VRAYLAR, NURTEC ODT, GEMTESA, UBRELVY, TZIELD, Korlym, Dexcom G6 Transmitter, ELIQUIS.
Industry payments across TX — which companies pay providers there.
